<DOC>
	<DOCNO>NCT01339507</DOCNO>
	<brief_summary>The purpose study evaluate comfort BEPREVE compare LASTACAFT instillation .</brief_summary>
	<brief_title>A Patient Reported Ocular Comfort Assessment Comparing Bepreve Lastacaft</brief_title>
	<detailed_description>After one drop instill subject complete comfort assessment 1 , 3 , 5 , 10 minute drop instillation .</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Alcaftadine</mesh_term>
	<criteria>Each patient must meet follow criterion enrol study : 1 . Are male female least 18 year age diagnose allergic conjunctivitis . 2 . Have allergic ocular symptom within last three day . 3 . Are willing/able follow instruction study investigator his/her staff . 4 . Have sign informed consent approve Institutional Review Board Independent Ethics Committee . Patients meet follow criterion exclude study : 1 . Have know hypersensitivity either BEPREVE™ LASTACAFT® component test article ( include `` procedural '' medication anesthetic and/or fluorescein drop , dilate drop , etc. ) . 2 . Have active corneal pathology note study eye screen visit . Active corneal pathology define corneal pathology non stable , great mild , compromise assessment safety efficacy treatment . 3 . Are pregnant nursing/lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>